Mersana Therapeutics
MRSN
#8919
Rank
S$0.18 B
Marketcap
S$36.44
Share price
0.43%
Change (1 day)
-59.50%
Change (1 year)

Earnings for Mersana Therapeutics (MRSN)

Earnings in 2025 (TTM): -S$96.71 Million

According to Mersana Therapeutics's latest financial reports the company's current earnings are S$34.76 Million. In 2024 the company made an earning of -S$88.79 Million, an increase over its 2023 earnings that were of -S$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Mersana Therapeutics from 2016 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$96.71 Million8.92%
2024 -S$88.79 Million-59.94%
2023 -S$0.23 Billion-15.94%
2022 -S$0.27 Billion20.08%
2021 -S$0.22 Billion93.16%
2020 -S$0.12 Billion212.12%
2019 -S$36.42 Million-56.1%
2018 -S$82.96 Million66.02%
2017 -S$49.97 Million182.53%
2016 -S$17.69 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-S$0.2 Billion 101.07%๐Ÿ‡บ๐Ÿ‡ธ USA